Multimodal treatment of testicular cancer: chemotherapy, surgery or radiotherapy?

被引:0
作者
Nestler, Tim [1 ]
Schmelz, Hans [1 ]
Mueller, Arndt-Christian [2 ]
Seidel, Christoph [3 ]
机构
[1] Bundeswehrzentralkrankenhaus Koblenz, Klin Urol, Rubenacherstr 170, D-56072 Koblenz, Germany
[2] RKH Kliniken Ludwigsburg Bietigheim, Klin Radioonkol & Strahlentherapie, Ludwigsburg, Germany
[3] Univ Klinikum Hamburg Eppendorf, Klin Onkol Hamatol & Stammzelltransplantat Mit Ab, Hamburg, Germany
来源
UROLOGIE | 2022年 / 61卷 / 12期
关键词
Guideline; Staging; Seminoma; Neoplasmmetastases; Adjuvant chemotherapy; LYMPH-NODE DISSECTION; GERM-CELL TUMORS; PHASE-II TRIAL; COMBINATION CHEMOTHERAPY; CISPLATIN; SEMINOMA; CARBOPLATIN; IFOSFAMIDE; BLEOMYCIN; ETOPOSIDE;
D O I
10.1007/s00120-022-01953-x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Metastatic testicular germ cell tumors patients require histology- and stage-appropriate therapy to achieve optimal therapeutic outcomes. Objectives: This work focuses on the interdisciplinary presentation of current recommendations for the treatment of metastatic germ cell tumor patients. Materials and methods: The interdisciplinary recommendations were formulated based on the German S3 guideline and supplemented by recent literature. Results: Using a stage-specific and guideline-based treatment approach, interdisciplinary cooperation between urology, oncology, and radiotherapy is mandatory to successfully achieve a high rate of cure and, in the case of complex advanced tumors, also themost effective therapy possible. The question of optimal treatment approaches for seminoma in cSII A/B remains particularly challenging. Conclusion: Since treatment of advanced ormultiple relapsed germ cell tumor patients remains complex, patients should be referred for an online second opinion (https:// urologie.ekonsil.org).
引用
收藏
页码:1315 / 1323
页数:9
相关论文
共 34 条
[1]   The PRIMETEST trial: Prospective phase II trial of primary retroperitoneal lymph node dissection (RPLND) in stage II A/B patients with seminoma. [J].
Albers, Peter ;
Lusch, Achim ;
Che, Yue ;
Arsov, Christian ;
Niegisch, Guenter ;
Hiester, Andreas .
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
[2]  
[Anonymous], 1997, J Clin Oncol, V15, P594
[3]  
[Anonymous], 2020, S3-Leitlinie zur Diagnostik, Therapie und Nachsorge des Melanoms
[4]   2-18fluoro-deoxy-D-glucose positron emission tomography (FDG-PET) for postchemotherapy seminoma residual lesions: a retrospective validation of the SEMPET trial [J].
Bachner, M. ;
Loriot, Y. ;
Gross-Goupil, M. ;
Zucali, P. A. ;
Horwich, A. ;
Germa-Lluch, J. -R. ;
Kollmannsberger, C. ;
Stoiber, F. ;
Flechon, A. ;
Oechsle, K. ;
Gillessen, S. ;
Oldenburg, J. ;
Cohn-Cedermark, G. ;
Daugaard, G. ;
Morelli, F. ;
Sella, A. ;
Harland, S. ;
Kerst, M. ;
Gampe, J. ;
Dittrich, C. ;
Fizazi, K. ;
De Santis, M. .
ANNALS OF ONCOLOGY, 2012, 23 (01) :59-64
[5]   Metastatic seminoma treated with either single agent carboplatin or cisplatin-based combination chemotherapy:: a pooled analysis of two randomised trials [J].
Bokemeyer, C ;
Kollmannsberger, C ;
Stenning, S ;
Hartmann, JT ;
Horwich, A ;
Clemm, C ;
Gerl, A ;
Meisner, C ;
Rückerl, CP ;
Schmoll, HJ ;
Kanz, L ;
Oliver, T .
BRITISH JOURNAL OF CANCER, 2004, 91 (04) :683-687
[6]   Improved clinical outcome in recent years for men with metastatic nonseminomatous germ cell tumors [J].
Carver, Brett S. ;
Serio, Angel M. ;
Bajorin, Dean ;
Motzer, Robert J. ;
Stasi, Jason ;
Bosl, George J. ;
Vickers, Andrew J. ;
Sheinfeld, Joel .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (35) :5603-5608
[7]   The Impact of Bleomycin on Retroperitoneal Histology at Post-Chemotherapy Retroperitoneal Lymph Node Dissection of Good Risk Germ Cell Tumors [J].
Cary, K. Clint ;
Pedrosa, Jose A. ;
Kaimakliotis, Hristos Z. ;
Masterson, Timothy A. ;
Einhorn, Lawrence H. ;
Foster, Richard S. .
JOURNAL OF UROLOGY, 2015, 193 (02) :507-512
[8]   Questioning the Value of Fluorodeoxyglucose Positron Emission Tomography for Residual Lesions After Chemotherapy for Metastatic Seminoma: Results of an International Global Germ Cell Cancer Group Registry [J].
Cathomas, Richard ;
Klingbiel, Dirk ;
Bernard, Brandon ;
Lorch, Anja ;
Garcia del Muro, Xavier ;
Morelli, Franco ;
De Giorgi, Ugo ;
Fedyanin, Mikhail ;
Oing, Christoph ;
Haugnes, Hege Sagstuen ;
Hentrich, Marcus ;
Fankhauser, Christian ;
Gillessen, Silke ;
Beyer, Jorg .
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (34) :3381-+
[9]   A randomized phase III study comparing standard dose BEP with sequential high-dose cisplatin, etoposide, and ifosfamide (VIP) plus stem-cell support in males with poor-prognosis germ-cell cancer. An intergroup study of EORTC, GTCSG, and Grupo Germinal (EORTC 30974) [J].
Daugaard, G. ;
Skoneczna, I. ;
Aass, N. ;
De Wit, R. ;
De Santis, M. ;
Dumez, H. ;
Marreaud, S. ;
Collette, L. ;
Lluch, J. R. G. ;
Bokemeyer, C. ;
Schmoll, H. J. .
ANNALS OF ONCOLOGY, 2011, 22 (05) :1054-1061
[10]   False-positive fluorodeoxyglucose positron emission tomography results after chemotherapy in patients with metastatic seminoma [J].
Decoene, Jasper ;
Winter, Christian ;
Albers, Peter .
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2015, 33 (01) :23.e15-23.e21